Management of Cytomegalovirus Infection in Allogeneic Hematopoietic Stem Cell and in Solid Organ Transplantation: Updated Recommendations by the GITMO, SITO, SIMIT, and AMCLI Italian Societies

Documenti analoghi

• Resistant/Refractory Cytomegalovirus Retinitis in Solid Organ and Hematopoietic Stem Cell Transplant Recipients: The Cause‐or‐Consequence Dilemma
  di: Renato Pascale, et al.
  Pubblicazione: (2026)
• Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study
  di: Estela Giménez, et al.
  Pubblicazione: (2025)
• Reduction in Length of Hospital Stays for Allogeneic Hematopoietic Stem‐Cell Transplantation in the Letermovir Era
  di: Hiroki Hosoi, et al.
  Pubblicazione: (2025)
• Cytomegalovirus Infection After CD‐34 Selected Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis
  di: Brennan Collis, et al.
  Pubblicazione: (2025)
• Molecular Profile and Dynamics of Commensal Viruses in Brazilian Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
  di: Gabriel Montenegro de Campos, et al.
  Pubblicazione: (2025)